These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2852215

  • 1. Increase in diazepam binding inhibitor-like immunoreactivity (51-70) in Huntington's disease.
    Ball JA, Burnet PW, Bretherton-Watt D, Bloom SR.
    J Neurol Sci; 1988 Dec; 88(1-3):177-84. PubMed ID: 2852215
    [Abstract] [Full Text] [Related]

  • 2. Diazepam binding inhibitor (DBI) increases after acute stress in rat.
    Ferrarese C, Mennini T, Pecora N, Pierpaoli C, Frigo M, Marzorati C, Gobbi M, Bizzi A, Codegoni A, Garattini S.
    Neuropharmacology; 1991 Dec; 30(12B):1445-52. PubMed ID: 1664070
    [Abstract] [Full Text] [Related]

  • 3. Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine/beta-carboline recognition site.
    Miyata M, Mocchetti I, Ferrarese C, Guidotti A, Costa E.
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1444-8. PubMed ID: 3029781
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL, Waldvogel HJ, Glass M, Faull RL.
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [Abstract] [Full Text] [Related]

  • 5. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M, Dragunow M, Faull RL.
    Neuroscience; 2000 Jul; 97(3):505-19. PubMed ID: 10828533
    [Abstract] [Full Text] [Related]

  • 6. Diazepam binding inhibitor (DBI) processing: immunohistochemical studies in the rat brain.
    Alho H, Bovolin P, Slobodyansky E.
    Neurochem Res; 1990 Feb; 15(2):209-16. PubMed ID: 2159126
    [Abstract] [Full Text] [Related]

  • 7. Benzodiazepine and GABA receptors in early Huntington's disease.
    Walker FO, Young AB, Penney JB, Dovorini-Zis K, Shoulson I.
    Neurology; 1984 Sep; 34(9):1237-40. PubMed ID: 6087209
    [Abstract] [Full Text] [Related]

  • 8. Diazepam binding inhibitor-like immunoreactivity(51-70): distribution in human brain, spinal cord and peripheral tissues.
    Ball JA, Ghatei MA, Sekiya K, Krausz T, Bloom SR.
    Brain Res; 1989 Feb 13; 479(2):300-5. PubMed ID: 2924161
    [Abstract] [Full Text] [Related]

  • 9. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat.
    Bovolin P, Schlichting J, Miyata M, Ferrarese C, Guidotti A, Alho H.
    Regul Pept; 1990 Jul 30; 29(2-3):267-81. PubMed ID: 2171047
    [Abstract] [Full Text] [Related]

  • 10. Distribution of a putative endogenous modulator of the GABAergic system in human brain.
    Ferrarese C, Appollonio I, Frigo M, Piolti R, Tamma F, Frattola L.
    Neurology; 1989 Mar 30; 39(3):443-5. PubMed ID: 2927661
    [Abstract] [Full Text] [Related]

  • 11. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
    Dawbarn D, De Quidt ME, Emson PC.
    Brain Res; 1985 Aug 12; 340(2):251-60. PubMed ID: 2862959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Huntington's disease: changes in tachykinin content in postmortem brains.
    Arai H, Emson PC, Carrasco LH.
    Ann Neurol; 1987 Nov 12; 22(5):587-94. PubMed ID: 2447825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brain.
    Ferrero P, Costa E, Conti-Tronconi B, Guidotti A.
    Brain Res; 1986 Dec 03; 399(1):136-42. PubMed ID: 3801915
    [Abstract] [Full Text] [Related]

  • 16. [Functional involvement of endogenous anxiogenic neuropeptide in brains].
    Katsura M, Ohkuma S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun 03; 24(3):119-23. PubMed ID: 15291240
    [Abstract] [Full Text] [Related]

  • 17. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE, Landis DM, Zalneraitis EL.
    Brain Res; 1983 Dec 19; 289(1-2):11-26. PubMed ID: 6198034
    [Abstract] [Full Text] [Related]

  • 18. The endogenous allosteric modulation of GABAA receptor subtypes: a role for the neuronal posttranslational processing products of rat brain DBI.
    Slobodyansky E, Berkovich A, Bovolin P, Wambebe C.
    Adv Biochem Psychopharmacol; 1990 Dec 19; 46():51-60. PubMed ID: 1963270
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions.
    Costa E, Guidotti A.
    Life Sci; 1991 Dec 19; 49(5):325-44. PubMed ID: 1649940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.